According to a recent report, actively participating in colorectal cancer screening can significantly reduce the risk of death from the disease. The study, covered by News-Medical, highlights that people who undergo regular screening have a much lower chance of dying from colorectal cancer compared to those who do not screen. The findings reinforce the value of routine screening for adults starting at age 45 or earlier based on risk factors.

Key Takeaways

  • Active screening for colorectal cancer is linked to a drastic reduction in death risk.
  • The report emphasizes that screening can catch cancer early or prevent it by removing precancerous polyps.
  • Common screening methods include colonoscopy, fecal immunochemical tests (FIT), and stool DNA tests.
  • Guidelines recommend average-risk adults begin screening at age 45.
  • Regular screening is one of the most effective ways to lower colorectal cancer mortality.

What the Report Found About Active Screening

The report, originally published by News-Medical, analyzed data from large populations and found that individuals who actively engaged in screening had a substantially lower risk of dying from colorectal cancer. While the exact percentage reduction was not specified in the summary, the word “drastically” indicates a large effect. The study likely compared screened versus unscreened groups over many years, adjusting for other factors.

Colorectal cancer is the third most common cancer diagnosed in both men and women in the United States, and it is the second leading cause of cancer death. Screening can find cancer at an early stage when treatment is most effective, and it can also prevent cancer by detecting and removing polyps before they become malignant.

Why Active Screening Matters

Active screening means that individuals take the initiative to get screened according to guidelines, rather than waiting for symptoms. Many people avoid screening due to discomfort, embarrassment, or lack of awareness. However, the new evidence from the report suggests that the benefits far outweigh any inconvenience.

The U.S. Preventive Services Task Force recommends that adults aged 45 to 75 be screened for colorectal cancer. Several options are available, including colonoscopy every 10 years, FIT every year, or stool DNA tests every three years. The choice depends on personal preference and risk factors.

How Screening Reduces Death Risk

Screening reduces colorectal cancer death risk through two main mechanisms. First, it detects cancer early when it is still localized and more treatable. Second, it identifies and removes precancerous polyps, preventing the cancer from ever developing. The report’s findings align with decades of research showing that screening saves lives.

Despite the proven benefits, screening rates remain suboptimal. According to the American Cancer Society, about one in three adults aged 50 to 75 have not been screened as recommended. The new report may encourage more people to schedule their screening.

Frequently Asked Questions

What is the best screening test for colorectal cancer?

There is no single “best” test for everyone. Colonoscopy is considered the gold standard because it allows the doctor to view the entire colon and remove polyps during the same procedure. However, stool-based tests like FIT are less invasive and can be done at home. The best test is the one that gets done.

At what age should I start colorectal cancer screening?

Most guidelines recommend starting regular screening at age 45 for people at average risk. Those with a family history of colorectal cancer or certain genetic conditions may need to start earlier. Talk to your doctor about your personal risk and the right age to begin.

Does screening always prevent colorectal cancer death?

No screening test is 100% effective, but regular screening dramatically reduces the risk of dying from colorectal cancer. Some cancers may grow between screenings or be missed, but the overall benefit is substantial. The report from News-Medical confirms that active screening is one of the most powerful tools we have against this disease.

For more details, readers are encouraged to consult the original report on News-Medical and speak with their healthcare provider about the best screening schedule for them.

This is an original report by Vital Signs Today, informed by reporting from Google News. Read the original source.

This article is for information only and is not medical advice. See our Medical Disclaimer.